in Newswire December 7, 2017

Lawsuit Claims Pharma Companies Downplayed Risks of Opioid Use

by Erin Gilmore

Last Updated on December 7, 2017

Philadelphia Federation of Teachers Health and Welfare Fund v. Purdue Pharma, L.P. et al.

Filed: October 23, 2017 § 2:17-cv-04746

Purdue Pharma, L.P., and three others have been named as defendants in a proposed class action that claims they misrepresented the efficacy and risks of using opioids for long-term and chronic pain management.

Last Updated on December 7, 2017 — 4:12 PM

Erin Gilmore

erin@classaction.org

Erin works primarily on ClassAction.org’s newswire, reporting on cases as they happen. She is an honest writer, a faithful friend, and a mediocre bassist.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.